One of the most pressing global challenges of our time is food security. NAPIGEN is addressing the unmet needs of future food demands through our proprietary mitochondrial gene editing technology. We are creating hybrid wheat, rice, and other crop plants that boost yields to unprecedented levels and are favorable to farmers and consumers.
Mitochondria are essential for human cells as the major source of metabolic energy. Disruption of mitochondrial functions due to mutations in mitochondrial DNA can cause severe degenerative and developmental disorders such as Kearns-Sayre syndrome and Leber Hereditary Optic Neuropathy. Mitochondrial mutations are also known to correlate with Alzheimer’s and Parkinson’s diseases, and aging. NAPIGEN is developing new gene editing technologies to provide potential cures for mitochondrial diseases.
Mitochondria are sites of many key metabolic pathways in industrial microbes. They are also the sites of energy production and reservoirs for chemical-reducing powers. Utilizing their superb environment for biosynthesis, NAPIGEN is turning mitochondria into subcellular biofactories to produce various high-value compounds efficiently. Our product targets include complex nutraceutical and pharmaceutical compounds.